Frontiers in pharmacology

PHCL 7600 The course is intended to introduce students to cutting-edge pharmacology research and to the range of research opportunities available within the Pharmacology Training Program. A series of presentations will focus on cellular signaling mechanisms, mechanisms of drug actions, pathways relevant to cancer, neuroscience, and cardiac biology, as well as other areas. The class format is flexible and discussion oriented. There are no exams or tests. Each class will consist of a ~40 min presentation, followed by a student-led discussion. The discussion may include questions about the research field, specific research presented, or even general questions of relevance to pharmacology students.

[1]  T. O'donohue,et al.  The opiomelanotropinergic neuronal and endocrine systems , 1982, Peptides.

[2]  J. Marx Cloning the acetylcholine receptor genes. , 1983, Science.

[3]  P. Molinoff,et al.  Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists. , 1983, The Journal of pharmacology and experimental therapeutics.

[4]  R. Meganathan,et al.  Biosynthesis of o-succinylbenzoic acid in a men- Escherichia coli mutant requires decarboxylation of L-glutamate at the C-1 position. , 1981, Biochemistry.

[5]  J. Scott,et al.  Rapid decrease in rat brain beta adrenergic receptor binding during combined antidepressant alpha-2 antagonist treatment. , 1983, The Journal of pharmacology and experimental therapeutics.

[6]  J. Oates,et al.  Increased production of prostaglandin D2 in patients with systemic mastocytosis. , 1980, The New England journal of medicine.

[7]  M. Palkovits,et al.  Distribution of vasoactive intestinal polypeptide (VIP) in the rat brain stem nuclei , 1982, Brain Research.

[8]  G. Mannering,et al.  Sequential administrations of polyriboinosinic acid and polyribocytidylic acid induce interferon and depress the hepatic cytochrome P-450-dependent monooxygenase system. , 1982, Biochemical and biophysical research communications.

[9]  H. Bourne,et al.  Fibroblast defect in pseudohypoparathyroidism, type I: reduced activity of receptor-cyclase coupling protein. , 1981, The Journal of clinical endocrinology and metabolism.